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1. Introduction 
Hydrodynamic gene delivery (HGD) is an established method of the last decade where 
macromolecules, non-normally permeable to cell membrane, are delivered intracellular. 
The basic principle is that a large volume of solution, containing genes or 
oligonucleotides, RNA, proteins or other compounds, is infused rapidly in circulation to 
permit the entrance of these substances to parenchymal cells. Excellent review papers are 
published summarizing the principles, the applications and the progress that has been 
made in this field1-10 The aim of this chapter is to describe the basic principles of the 
hydrodynamic gene delivery, the surgical procedures in all animal models and the 
reflection of our scope for the future development.  
2. Basics of hydrodynamic gene delivery 
Hydrodynamic gene delivery is developed based in our knowledge on vasculature, fluid 
properties and cell membrane permeability. Based on the studies of Zhang et al.1, 
Kobayashi et al.2, Lecocq et al.3 and Al-Dosari et al.5, the rapid infusion of large solution 
containing macromolecules, non-normally permeable to cell membrane, generates high 
hydrodynamic pressure in the circulation refluxing to the target organ. The enlarged 
perivenous area, by the extravasation of the infused solution, generates high pressure in 
the exterior of the cells. When this pressure reaches a certain level, defects (pores) are 
been created on the cell membrane leading to the insertion of the macromolecules 
intracellular. After a few seconds, while the pressure declines at post-injection period, the 
defects are restoring, trapping inside the cytoplasm the infused molecules. Finally, the 
body adapts the volume overload within time and the homeostasis is again balanced. We 
believe that the sequence of these events occur in all surgical protocols, from tail vein 
injection in mice to specific organ infusion in large animals.  
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The vehicle for the molecules is Normal Saline, Ringer’s Solution or Phosphate Buffered 
Saline and the dosage range from 0.1 to 10 mg/kg, depending on the application. The 
molecules can be DNA, as plasmid, fragment or artificial chromosome, RNA, single or 
double stranded, genomic or not, polymers, proteins and small compounds. The main 
application of the hydrodynamic delivery is the therapy studies, especially genes 
encoding secretory proteins which can be even isolated and purified. A different area of 
interest is the gene function analysis in a whole animal instead of a cell culture; the 
transfection is applied with the hydrodynamic technique and the conclusions are 
withdrawn from the whole animal. The study of DNA sequences can be achieved with 
HGD, where promoters, introns, enhancers, suppressors can be delivered intracellular in 
whole animal. Moreover new animal models are possible to be created for study human 
diseases, mainly viral due to the fact that they are species specific5,8,10. 
3. Animal models 
3.1 Mice 
The majority of the research protocols of the hydrodynamic delivery in mice are  
based on tail vein injection, due to the ease of application and the positive results11,14-53. In 
the mouse tail there are four blood vessels, the lateral ones being the veins. The animal is 
placed in a restrain box or in light sedation and prior to injection the tail vein should be 
dilated with a tourniquet, immersed in hot water (40 0C for 1-2 min) (photo 1)or placed in 
incubator at 370C for 10-15 min. A 27g-30g needle at a very shallow angle is commonly used, 
while the injection of small amount of fluid is mandatory for the verification of the correct 
placement of the needle (photo 2). Then, the solution of a total 1.5-2 ml, equivalent to 8-10% 
of body weight, is rapidly infused, within 5 to10 seconds4. 
 
Photo 1. The animal is light sedation with the tail is placed in hot water for dilatation of the 
veins 
A surgical procedure has been established by Zhang et al15 for delivering macromolecules 
in liver under general anesthesia. After a midline incision at the abdomen, the portal vein 
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was identified and the solution was injected with a 30g needle while the hepatic vein and 
the inferior vena cava had been occluded. Modification of this procedure, by the same 
group, involved the solution being infused in the hepatic vein with occlusion of the portal 
vein, vena cava and the hepatic artery. At the end of the infusion gentle pressure was 
applied at the insertion point to minimize hemorrhage. The midline incision was closed in 
standard technique. 
 
Photo 2. The tail is rotated 90o degrees and the needle is inserted in a shallow angle-arrows 
are depicting the dilated vein 
For hydrodynamic gene delivery in mice muscle, under general anesthesia, a small latex 
tourniquet is applied above the knee and a small incision is made to expose the great 
saphenous vein. The infusion of the gene solution precedes the placement of a 30g catheter 
in the tail vein, and two minutes later the tourniquet is removed5,6. 
3.2 Rat 
The tail vein injection is the most common procedure in rats57-65 as in mice with small 
modifications. For hydrodynamic infusion a needle or an over-the-needle intravenous 
catheter 23-27g can be used. The over-the-needle catheter insertion in the vein is followed by 
needle withdrawal and catheter advancement (photo 3). Blood entrance in the catheter 
confirms the correct placement of the catheter, secured by taping to the tail and connected 
with an extension to the infusion pump at a rate of 1-2 ml/sec54. 
For selective infusion in rat’s liver, the animal should be in general anesthesia and with the aid 
of a midline incision, the inferior vena cava (IVC) is isolated with 4-0 suture above and below 
the liver. At a midpoint, a 21-gauge needle is positioned while around the hole a 4-0 suture is 
secured to minimize leakage. Two minutes after the injection, the sutures above and below the 
IVC are removed and midline incision is closed with 4-0 absorbable suture7,8,9.  
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Photo 3. The vein is dilated with the aim of a tourniquet and an over-the-needle catheter is 
inserted. 
A surgical protocol, modifying the above technique, has been developed by Inoue et al.10 for 
selective infusion in liver. A 0.5mm silicon tube was advanced to the inferior vena cava 
(IVC) through the right common iliac vein for rapid injection of the solution, whereas the 
suprahepatic and the infrahepatic IVC were clamped. At the end of the procedure, clamps 
were removed and gently pressure was applied in the puncture point to minimize 
hemorrhage. Sawyer’s group67 verified Inoue results and calculated the optimum volume of 
DNA solution per g of liver to be 0.6 ml and the flow rate at 15 ml of solution per min per g 
liver for optimal hydrodynamic gene delivery to the liver. 
A different approach for infusion in liver is to insert a 26g elastic cannula at the middle of 
the hepatic artery, through the gastroduodenal artery, and the celiac artery, the portal 
vein and the inferior vena cava are temporally clamped. Injection of the solution in the 
arterial vasculature is followed, fifteen second later, by clamps removal and 
gastroduodenal artery ligation11.  
For hydrodynamic infusion in kidney, a 26-g catheter is inserted distally to clamped renal 
vein, at its origin, and blood flow is re-established immediately after the rapid infusion. 
Pressure should be applied for homeostasis and the abdomen is closed in standard 
technique 68,12.  
Hydrodynamic gene delivery in hind limb muscle is carried out through an inserted 28g 
needle catheter  in the saphenous vein in direction to the knee, while a placed tourniquet, 
at a proximal part, forces the solution into the small veins ending up in the muscle tissue 
cells for 1-2 min post-injection13,14,15,16(photo 4). According to Danialou et al.17 gene 
delivery in rat’s muscle was applied by a 23 g butterfly needle positioned in the femoral 
artery, directed distally, and the obstruction of venous circulation was originated by a 
clamp on the femoral vein. Before the hydrodynamic infusion 2 mg of papaverin and 2 mg 
of histamine (1 mg/ml) in normal saline were injected and, 20 minutes following the 
infusion, the vascular clamp was removed. 
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Photo 4. The saphenous vein prior to dilatation(left), after the placement of a tourniquet 
(middle), exposed after a small skin incision (right). 
A protocol for hydrodynamic gene delivery in rat’s heart was developed by de Carvalho 
and associates18. An incision at the fourth intercostal space exposed the heart and the aorta 
was identified, dissected from surrounding tissue and clamped. An injection, of 200 µl PBS 
solution containing naked DNA in the left ventricle over 3 seconds, was followed, twenty 
seconds later, by clamp removal. During the procedure an ultrasound probe was attached 
toward the heart with an intensity of 1 MHz and power of 2 W/cm2   
3.3 Rabbit 
Eastman et al.19, in 2002, applied hydrodynamic gene delivery in larger animal model than 
rodents, avoiding heart failure that could be encountered when applied due to the large 
amount of infused solution. In anesthetized rabbit, in dorsal recumbent position, a right 
paramedian incision at the neck revealed the right jugular for the placement of a 20-g 
angiographic sheath and the insertion a 0.025 inch hydrophilic guide wire into a hepatic 
vein, under fluoroscopic control. The wire was replaced by a 5F balloon occlusion catheter 
in selected hepatic vein and inflated. A small amount of contrast material confirmed the 
proper position and the medium containing the macromolecule was infused rapidly at a rate 
5 ml/sec at an 80 ml total volume. At the end of infusion the catheter was withdrawn and 
the incision was closed in standard technique.  
The researchers modified this technique to block venous outflow during infusion. A balloon 
catheter was inserted in the hepatic vein, as described above, while from a second skin 
incision, over the femoral vein, a 20-g angiographic sheath was positioned and a 0.025 
hydrophilic guide wire was inserted, through the sheath, into the proximal inferior vena 
cava (IVC) under fluoroscopic guidance (photo 5). A 7F introducer sheath substituted the 
angiographic sheath, reaching the distal IVC and enabling the introduction of a 5F XXL 
angioplasty catheter to the intrahepatic portion of the IVC to inhibit all venous outflow. 
After the infusion all catheters were removed. 
Subsequently, a whole organ isolation protocol was demonstrated with the primary aid of a 
balloon catheter positioned, as already described through the jugular vein, above the upper 
hepatic veins. A second balloon catheter was inserted through the femoral vein between the 
lower hepatic veins and the renal veins, while, a third 4F pediatric pigtail infusion catheter 
was advanced from the controlateral femoral vein to a point between the two occlusion 
catheters. Vasovagal response was diminished by glycopyrrolate injection (0.01 mg/Kg) 
followed by the inflation of the catheters, and injection of a radiopaque solution, prior to the 
gene delivery, demonstrated the absence of a leakage. At the end of the surgical procedure 
all catheters were removed and bleeding was controlled.  
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Photo 5. The sheath is being inserted in the femoral vein of a rabbit. 
 
Photo 6. Instertion of a needle catheter in the portal vein, under ultrasound guidance. 
The same group revealed the possibility to infuse percutaneously in the portal system, with 
a 20-g needle under ultrasound guidance, the gene solution ( photo 6). A small amount of 
contrast material was firstly delivered to confirm the correct placement of the needle in 
order a 0.025 glide wire to be advanced through the needle at liver parenchyma. An 
angiographic sheath was, then, placed over the wire and the position was verified again 
fluoroscopically. After the infusion, the catheter was removed and hemostasis was achieved 
with manual pressure at the insertion point.  
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3.4 Swine  
Swine is the most popular large animal model for hydrodynamic gene delivery among the 
researcher groups the past years. Yoshino and associates20 have developed a surgical 
protocol based on Eastman’s research. Upon the insertion of an occlusion balloon catheter, 
through the right external jugular vein, into the left hepatic vein under fluoroscopic 
guidance, the hepatic artery and the portal vein were identified and clamped after a midline 
incision. The injection of 200 ml of saline, to wash out the liver blood through a catheter 
placed proximal to the clamp in the portal vein, was followed by the occlusion of the hepatic 
veins. The occlusion catheter was removed thirty seconds after the application of the 
hydrodynamic delivery, along with the clamps at the portal and hepatic veins, and the 
hepatic artery. The midline incision was closed in standard technique. 
A modification of the technique above was introduced by Suda et al.68 and Kamimura et 
al.21. Through an 18g catheter placed in the jugular vein, a 0.035 guide wire was inserted into 
the inferior vena cava (IVC) under fluoroscopic guidance. A 9F balloon catheter was 
advanced into the right lateral liver lobe over the guide wire, while two occlusions balloons 
8F were inserted, one from the femoral vein into the IVC and the other one from the 
superior mesenteric vein into the portal trunk, to block leakage from the injected solution. 
Suda’s group68, also, demonstrated a successful gene delivery in kidney with the aid of the 
balloon catheter inserted to the right renal vein, instead of the right liver lobe, and the IVC 
occlusion balloon, using the technique as already described. 
Habib group22,23 developed a minimal invasive surgical protocol to deliver gene in liver 
lobe’s segment. After a right paramedian incision at the neck, the right external jugular vein 
was identified and isolated from the surrounding tissues and an introducer sheath was 
positioned in place. A hydrophilic catheter 5F was advanced, over a 0.035 guide wire 
previously positioned under fluoroscopy to the right hepatic vein, at the periphery of the 
right lateral liver lobe. A custom made 7F rigid balloon catheter, with multiple holes at the 
tip (photo 7), replaced the hydrophilic catheter remained in place for 10 minutes, after the 
infusion, to verify fluoroscopically the occlusion of the hepatic vein (photo 8). At the end of 
the procedure, the catheter was deflated, removed from the external jugular vein and a 3-0 
absorbable ligature was used proximal to the puncture site to control bleeding.  
Danialou et al.76, described a surgical protocol for gene delivery to hind limb muscle 
introducing an 8F catheter in the femoral artery directing distally, while a tourniquet was 
placed around the limb proximal to the catheter. 10 mg of papaverine was delivered in the 
arterial line over 30 sec, while femoral vein had been clamped, followed, 5 min later, by the 
injection of 10 mg of papaverine mixed with 10 mg of histamine. The gradual removal of the 
tourniquet, within 10 min from the gene infusion, was followed by catheter and clamp 
removal. The effects of histamine, if present, were counteracted by 50 mg of diphenhydramine 
and dextran volume expander. A different approach, for hydrodynamic delivery in muscle, 
has been described by Kamimura and associates24. Over a 0.035 guide wire, positioned to the 
femoral vein under fluoroscopic guidance through an 18g catheter in the jugular vein, an 8F 
balloon catheter is positioned. The isolated hind limb, by a rubber band proximally sited, 
remained in place until the infused balloon was slowly deflated 20 min after the infusion. 
For hydrodynamic gene transfer to heart tissue, Alino et al.25 placed a 7F Swan-Ganz 
catheter and a 6 F multipurpose catheter at the coronary sinus under fluoroscopic guidance, 
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through two 7F sheaths in the right and the left jugular veins, respectively. The coronary 
sinus vein was sealed by the Swan-Ganz catheter while the plasmid was injected through 
the multipurpose catheter and three minutes later the catheters were removed. 
 
Photo 7. The custom made rigid-catheter with multiple holes at the side and a single at the 
center, enabling the infusion of large volumes of solution in small period of time without 
leakage. 
 
Photo 8. Placement of the catheter under pluoroscopic assistance (left), and the infused liver 
lobe with the ballon inflated without leakage of the gene solution and a small amount of 
contrast material (right). 
3.5 Other animals - Human 
3.5.1 Canine  
Canine, as an animal model, is limited, mainly, in muscle gene delivery. After sedation, a 
20 g catheter is inserted in the great saphenous vein while a cuff has been positioned just 
above the stifle and inflated to 300 mm Hg pressure, to block blood flow. Before infusing 
the gene solution, 25ml of natural saline containing 4.2 mg of papaverine and 150 units of 
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heparin are delivered in 10sec, and five minutes later the solution containing the pDNA is 
injected at a rate of 2ml/sec72,75,26. 
3.5.2 Primates 
In nonhuman primates, Brunetti-Pierri’s group27,28 has established several different surgical 
protocols for gene delivery in liver. Saline solution (200ml) was firstly infused, followed by the 
vector injection in the portal vein, while its distal part and the hepatic artery had been 
occluded by vessel loops. The loops were retained in place for 30 minutes and the portal vein 
at the injection point was sutured by monofilament suture. In the second surgical protocol, the 
main strategy was to occlude not only the blood inflow but the outflow, as well. The surgical 
procedure described above was repeated and two umbilical tapes were passed around the 
infrahepatic IVC  and suprahepatic IVC. 20ml/kg of normal saline were intravenously infused 
to prevent hypotension during total hepatic occlusion. Saline was again infused, at a volume of 
12 to 13% of the total blood volume, through the portal vein catheter followed by the rapid 
occlusion of the infrahepatic and suprahepatic IVC and the hydrodynamic injection. In case of 
severe hypotension (mean arterial pressure less than 60 mm Hg) phenylephrine, at a dose of 40 
mg in 250 ml of saline, was administrated. In the third protocol, a catheter was placed in the 
IVC to retrieve the unabsorbed vector modifying the previous protocol, while in the next 
protocol the retrieved vector was reinjected to the portal vein 
A minimal invasive protocol was developed by the same research group. Two sheaths, 4F 
and 11 F, were positioned in the right and the left femoral vein, respectively, along with a 4F 
sheath in the left femoral artery. From the right femoral sheath, a custom made occlusion 
balloon-catheter was advanced in the IVC right arterial junction and deflated 7.5 to 15 min 
after the infusion from the catheter mounted in the hepatic artery, through the left femoral 
artery. Mild hypotension resolved with 20 ml/kg saline and phenylephrine to effect29. 
In nonhuman primates, hydrodynamic delivery in muscle has also been well established. 
Under general anesthesia, after the placement of a 20g intravenous catheter into the distal 
cephalic vein, for the forearm, or into the small saphenous vein, for the hind limb, a 
tourniquet, above the elbow or the knee, is inflated to a pressure of 450 mmHg. The gene 
solution is rapidly infusion at a rate of 2 ml/sec and 2 minutes post-injection the tourniquet 
is deflated55,72,73,30,31,32. 
3.5.3 Human 
There is only one publication about hydrodynamic gene delivery in humans, by Khorsandi 
et al.82. A modified balloon catheter was introduced in the femoral vein, after the infusion of 
local anesthetic at the puncture site, and reached the middle hepatic vein, under fluoroscopy 
guidance. Before injecting the gene solution, the correct placement of the catheter and the 
absence of back flow were verified by injecting contrast material. Upon the completion of 
the infusion, the catheter remained in place for 10 minutes and then removed; the patients 
were discharged from hospital the same day. 
4. Conclusion and future perspectives 
Hydrodynamic delivery of macromolecules, membrane-impermeable, to cytoplasm is a 
physical method that gains popularity over the last years. The simplicity of the procedures 
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as already described, the lack of sophisticated equipment and the produced results, lead the 
hydrodynamic delivery to become a clinically feasible procedure in the near future. There is 
already one clinical trial on humans and we believe that the refinement of the procedure and 
the delivery in tissues other than liver or muscle, with minimal tissue damage and maximal 
delivery, will aim to new drug discovery and potential treatment of several human diseases. 
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